For Genny Mack, Lupus was never just a word in a medical chart. It was a shadow that was always there. Growing up, he saw first hand what he meant to live with a year, unpredictable illness. “Lupus has always been a question mark, because my mom has a wolf,” Genny shares. But her mother’s approach was shaped by a different time and a different mindset. “It’s a classic example of the ancestral genealogy that came in front of me, taught. You just get involved with illness. She doesn’t talk about it too much. She just lives and takes her medicine.” This quiet endurance is familiar with many black families. Genny saw the limits of silence and resignation. She wanted something more, not only for herself but for everyone who comes after.
Living with wolf: beyond diagnosis
Genny was officially diagnosed around the age of 30, but warning signs began years ago. “Active weight loss. This happened to me. Some people have a drastic gain of weight from the drug, steroids, for example.” She has experienced all this: unpredictable flames, long hospitalizations, fatigue that can eliminate a week and continuous calculations on what will allow or not allow her body. “Just learning how to move the body again. You know. Do bed can be a terrible, awesome day.” It also points to the emotional weight. “We must be this powerful black woman and often we do not have the healthcare system that supports us.”
The general public is still not aware of the disease. Well, here are some facts:
- Lupus affects black women in two to three times the percentage of white women. They often develop it at a younger age and with more severe symptoms.1
- Lupus is one of the main causes of death among young women in color.2
- Up to 25 % of people with wolf are hospitalized each year, sometimes for weeks at a time.3
- Black women remain under -sized in clinical trials and wolf research. This leads to gaps in care, treatment and understanding.4
Genny wrote her own path with the disease. Has become a lawyer by organizing a support team called The wolf connection And talking about black women who are often rejected by health care providers, while not realizing their power. “The job of my life is to train people in the wolf, but also to show people that you can live a full life with the wolf,” he says. Genny also thinks it is important for people to know other options such as clinical trials that may be available. “We do not participate in these clinical trials and studies and we must be”
Genny rewrites what is possible by searching for answers, building community and demanding better than any corner of the healthcare system. It shows us that you do not need to accept what you inherited – you can ask for more, wait for more and create change for yourself and others. Her journey is not just about survival. This is about taking power, standing and inspiring a new generation to speak, display and claim the future they deserve. To find out more about Genny Mack and her visit to defense gennymack.com For events supported by science and useful resources in wolf, visit lupus.org.
If you or someone you love live with the wolf, consider joining a clinical trial. Participation is not just about taking a study drug. This is to make sure that black women’s experiences count and lead science forward.
Learn more about a current wolf clinical trial and how you can get involved:
Click here
Let’s change everything possible for ourselves and the next generation.
References
- Disease Control and Prevention Centers. “Systematic wolf erythematosus (sle) – wolf.” CDC, 2023.
- Yen, Ey, & Singh, RR “LUPUS-A Unrecognized Main Cause of Death in Young Women: Population-based Study Using National Death Certificates, 2000-2015.” Arthritis and rheumatology2018.
- Yelin, E., Trupin, L., & Tonner, C. “A prospective study study in systematic lupus erythematosus: the study of the results of the University of California”. Arthritis and rheumatismVol. 54, no. 3, 2006, pp. 894-902.
Drenkard, C., et al. “Challenges and opportunities for clinical trials to African Americans with p.” Current Rheumatology ReportsVol. 21, no. 10, 2019.
